XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa - Egyptian Knowledge Bank

352431

XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa

Article

Last updated: 29 Dec 2024

Overview Similar Items

Article

Efficacy and Safety and Mortality: Monitoring the patients on Rivaroxaban

Article

Safety and Mortality: Monitoring the Patients on Rivaroxaban

Article

EFFICACY AND SAFETY OUTCOMES OF RIVAROXABAN IN ACUTE DEEP VENOUS THROMBOSIS PATIENTS

Article

Apixaban in Patients with Post-Myocardial Infarction Left Ventricular Thrombus: A Randomized Clinical Trial

Article

Efficacy and Safety of Low Dose Rivaroxaban in Patients with Anterior Myocardial Infarction

Article

Rivaroxaban versus Warfarin in Treatment of Acute Lower Limb Deep Venous Thrombosis and its Affection on Quality of Life.

Article

Short Term Evaluation of Warfarin Versus Rivaroxaban Regimens in the Treatment of Deep Venous Thrombosis

Article

Comparative study of safety and effectiveness of rivaroxaban and warfarin in patients with acute deep venous thrombosis

Article

Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis

Article

Study of Embolic Cerebral Stroke in Atrial Fibrillation Patients. Severity, Recurrence and Outcome